TAG/ANTI-TAG SYSTEM FOR SIGNAL AMPLIFICATION IN IMMUNOASSAYS
Methods and kits for detecting analytes (such as a plurality of analytes) in a sample utilizing signal amplification (such as DMP-based chemical tag signal amplification) are provided.
1 . A method of detecting a plurality of analytes in a sample, comprising:
a) contacting the sample with a solid support comprising a capture reagent capable of specifically binding the plurality of analytes;
b) contacting the solid support with a plurality of detection antibodies or fragment thereof capable of specifically binding the plurality of analytes, wherein the plurality of detection antibodies or fragment thereof comprise at least:
i) a first detection antibody or fragment thereof capable of specifically binding a first analyte and comprising a first detectable label; and
ii) a second detection antibody or fragment thereof capable of specifically binding a second analyte and comprising a second detectable label;
c) contacting the solid support with a plurality of detection reagents, wherein the plurality of detection reagents comprise at least:
i) a first detection reagent capable of specifically binding to the first detectable label and comprising a first fluorescent label; and
ii) a second detection reagent capable of specifically binding to the second detectable label and comprising a second fluorescent label,
wherein at least one of the first and second detection reagents is an antibody or fragment thereof capable of specifically binding to the first or second detectable label; and
d) detecting the first fluorescent label and the second fluorescent label, thereby detecting the plurality of analytes.
2 . The method of claim 1 , wherein the capture reagent is an antibody or fragment thereof or a non-antibody capture reagent, optionally wherein the non-antibody capture reagent is an aptamer.
3 . The method of claim 1 , wherein:
the first analyte, the second analyte, or both are a protein;
the first analyte and the second analyte are different forms of the same analyte; and/or
the first analyte comprises a protein and the second analyte comprises a phosphorylated form of the same protein.
4 . The method of claim 1 , wherein:
(i) the first detectable label or the second detectable label comprises biotin, a dimethyl piperidine (DMP)-based chemical tag, digoxigenin, cucurbit[7]uril, O 6 -benzylguanine, a His tag comprising the amino acid sequence HHHHHH (SEQ ID NO:
1 ., a FLAG tag comprising the amino acid sequence DYKDDDDK (SEQ ID NO: 2), a Myc tag comprising the amino acid sequence EQKLISEEDL (SEQ ID NO: 3), a hemagglutinin tag comprising the amino acid sequence YPYDVPDYA (SEQ ID NO: 4, a fluorescent protein, HaloTag, or glutathione S-transferase; and/or
(ii) the first detection reagent or the second detection reagent comprises streptavidin, an antibody or fragment thereof that specific binds a dimethyl piperidine (DMP)-based chemical tag, an antibody or fragment thereof that specifically binds to digoxigenin, an antibody or fragment thereof that specifically binds to cucurbit[7]uril, SNAP tag (O 6 -alkylguanine-DNA alkyltransferase (AGT)), an antibody or fragment thereof that specifically binds to a His tag comprising the amino acid sequence HHHHHH (SEQ ID NO: 1), an antibody or fragment thereof that specifically binds to a FLAG tag comprising the amino acid sequence DYKDDDDK (SEQ ID NO: 2), an antibody or fragment thereof that specifically binds to a Myc tag comprising the amino acid sequence EQKLISEEDL (SEQ ID NO: 3), an antibody or fragment thereof that specifically binds to a hemagglutinin tag comprising the amino acid sequence YPYDVPDYA (SEQ ID NO: 4), an antibody or fragment thereof that specifically binds to a fluorescent protein, an antibody or fragment thereof that specifically binds to HaloTag, or an antibody or fragment thereof that specifically binds to glutathione S-transferase.
5 . The method of claim 1 , wherein:
the first detectable label and the second detectable label are different; and/or
the first detection reagent and the second detection reagent are different; and/or
the first fluorescent label and the second fluorescent label are different; and/or
the solid support comprises a bead.
6 . The method of claim 1 , further comprising contacting the sample with a plurality of solid supports, each comprising a different capture reagent, optionally wherein the plurality of solid supports comprises 2-500 solid supports, each comprising a different capture reagent.
7 . The method of claim 1 , wherein the first detectable label is biotin and the second detectable label is a dimethyl piperidine (DMP)-based chemical tag or is digoxigenin and wherein the first detection reagent is streptavidin and the second detection reagent is an antibody or fragment thereof capable of specifically binding to the DMP-based chemical tag or is an antibody or fragment thereof capable of specifically binding to digoxigenin; and/or
wherein the first fluorescent label is phycoerythrin and the second fluorescent label is a polymer dye, or wherein the first fluorescent label is a polymer dye and the second fluorescent label is phycoerythrin.
8 . The method of claim 1 , wherein the sample comprises cells, cell lysate, cell culture supernatant, extracellular vesicles, extracellular vesicle lysate, blood, serum, plasma, cerebrospinal fluid, urine, tissue, or tissue homogenate.
9 . The method of claim 1 , comprising:
a) contacting the sample with a solid support comprising a capture reagent capable of specifically binding to a protein involved in signal transduction;
b) contacting the solid support with a plurality of detection antibodies or fragment thereof capable of specifically binding the protein involved in signal transduction, wherein the plurality of detection antibodies or fragment thereof comprise at least:
i) a first detection antibody or fragment thereof capable of specifically binding the protein involved in signal transduction and a phosphorylated form of the protein involved in signal transduction and comprising biotin; and
ii) a second detection antibody or fragment thereof capable of specifically binding the phosphorylated protein involved in signal transduction and comprising a DMP-based chemical tag;
c) contacting the solid support with a plurality of detection reagents, wherein the plurality of detection reagents comprise at least:
i) a first detection reagent comprising streptavidin and a first fluorescent label; and
ii) a second detection reagent comprising an antibody or fragment thereof capable of specifically binding to the DMP-based chemical tag and comprising a second fluorescent label; and
d) detecting the first fluorescent label and the second fluorescent label, thereby detecting the plurality of analytes.
10 . A kit comprising:
a solid support comprising a capture reagent capable of specifically binding an analyte;
a first detection antibody or fragment thereof capable of specifically binding the analyte and comprising a first detectable label;
a second detection antibody or fragment thereof capable of specifically binding the analyte and comprising a second detectable label;
a first detection reagent capable of specifically binding to the first detectable label and comprising a first fluorescent label; and
a second detection reagent capable of specifically binding to the second detectable label comprising a second fluorescent label,
wherein at least one of the first and second detection reagents is an antibody or fragment thereof capable of specifically binding to the first or second detectable label.
11 . The kit of claim 10 , wherein the capture reagent is an antibody or fragment thereof or a non-antibody capture reagent, optionally wherein the non-antibody capture reagent is an aptamer.
12 . The kit of claim 10 , wherein:
the first detectable label is biotin and the second detectable label is a dimethyl piperidine (DMP)-based chemical tag or digoxigenin and the first detection reagent is streptavidin and the second detection reagent is an antibody or fragment thereof capable of specifically binding to the DMP-based chemical tag or an antibody or fragment thereof capable of specifically binding to digoxigenin; and/or
the first fluorescent label is phycoerythrin and the second fluorescent label is a polymer dye, or wherein the first fluorescent label is a polymer dye and the second fluorescent label is phycoerythrin.
13 . The kit of claim 10 , wherein the solid support is a bead.
14 . A method of detecting an analyte in two or more samples, comprising:
a) labeling a plurality of analytes in a first sample with a first detectable label to produce a labeled first sample and labeling a plurality of analytes in a second sample with a second detectable label to produce a labeled second sample;
a) contacting the labeled first sample and the labeled second sample with a solid support comprising a capture reagent capable of specifically binding at least one of the labeled analytes;
b) contacting the solid support with a plurality of detection reagents, wherein the plurality of detection reagents comprise at least:
i) a first detection reagent capable of specifically binding the first detectable label and comprising a first fluorescent label; and
ii) a second detection reagent capable of specifically binding the second detectable label and comprising a second fluorescent label, wherein at least one of the first and second detection reagents is an antibody or fragment thereof capable of specifically binding to the first or second tag; and
d) detecting the first fluorescent label and the second fluorescent label, thereby detecting the analyte from the first sample and the second sample.
15 . The method of claim 14 , wherein the capture reagent is an antibody or fragment thereof or a non-antibody capture reagent, optionally wherein the non-antibody capture reagent is an aptamer.
16 . The method of claim 14 , wherein the first sample is a reference sample and the second sample is a test sample.
17 . The method of claim 14 , wherein the analyte is a protein and/or the solid support is a bead.
18 . The method of claim 14 , wherein:
the first detectable label is biotin and the second detectable label is a dimethyl piperidine (DMP)-based chemical tag or digoxigenin and the first detection reagent is streptavidin and the second detection reagent is an antibody or fragment thereof capable of specifically binding to the DMP-based chemical tag or an antibody or fragment thereof capable of specifically binding to digoxigenin; and/or
the first fluorescent label is phycoerythrin and the second fluorescent label is a polymer dye, or wherein the first fluorescent label is a polymer dye and the second fluorescent label is phycoerythrin; and/or
the first fluorescent label and the second fluorescent label are different.
19 . The method of claim 14 , further comprising a plurality of solid supports, each comprising a different capture antibody, optionally wherein the plurality of solid supports comprises 2-500 solid supports, each comprising a different capture antibody.
20 . The method of claim 14 , further comprising comparing a level of the first fluorescent label and the second fluorescent label, thereby detecting a differential amount of the first analyte and the second analyte between the first and second samples.